Akash Tewari
Stock Analyst at Jefferies
(0.52)
# 2342
Out of 5,328 analysts
66
Total ratings
40.54%
Success rate
-5.99%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb | Maintains: Buy | 70 68 | 49.49 | 37.4% | 4 | Apr 23, 2025 | |
BMRN Biomarin Pharmaceuti... | Initiates Coverage On: Outperform | 95 | 62.7 | 51.52% | 2 | Nov 15, 2024 | |
BNTX BioNTech | Upgrades: Buy | 96 150 | 102.58 | 46.23% | 3 | Sep 17, 2024 | |
RLAY Relay Therapeutics | Upgrades: Buy | 11 16 | 3.31 | 383.38% | 3 | Sep 10, 2024 | |
NBIX Neurocrine Bioscienc... | Maintains: Strong Buy | 177 189 | 106.71 | 77.12% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 80 | 20.09 | 298.21% | 2 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 29 75 | 31.79 | 135.92% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 994 1015 | 794.79 | 27.71% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 42 50 | 30.63 | 63.24% | 5 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 37 75 | 39.26 | 91.03% | 4 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 31 | 14.68 | 111.17% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 32 40 | 7.24 | 452.49% | 2 | Dec 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 935 937 | 588.6 | 59.19% | 4 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 12 | 2.58 | 365.12% | 2 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 38 39 | 23.91 | 63.11% | 2 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 49 18 | 6.08 | 196.05% | 2 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 497 513 | 638.88 | -19.7% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 3.56 | 405.62% | 1 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 125 | 83.31 | 50.04% | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 8 11 | 12.92 | -14.86% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 30 4 | 5.15 | -30.1% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 17 | 1.36 | 1150% | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 6 4 | n/a | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 68 69 | n/a | n/a | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 75 | 43.03 | 74.3% | 2 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 151 | 326.72 | -53.78% | 1 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | 38.9 | -28.02% | 2 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 180 | n/a | n/a | 2 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 107 | n/a | n/a | 1 | Mar 12, 2021 |